M H Eckman1, A C Steere, R A Kalish, S G Pauker. Show Affiliations » 1. Department of Medicine, New England Medical Center, Boston, MA 02111, USA.
Abstract
Entities: Disease Species
Mesh: See more » Administration, OralAnti-Bacterial Agents/adverse effectsAnti-Bacterial Agents/economicsAnti-Bacterial Agents/therapeutic useCeftriaxone/adverse effectsCeftriaxone/economicsCeftriaxone/therapeutic useCephalosporins/adverse effectsCephalosporins/economicsCephalosporins/therapeutic useCost-Benefit AnalysisDecision TreesDoxycycline/adverse effectsDoxycycline/economicsDoxycycline/therapeutic useHumansInfusions, IntravenousInjections, IntravenousLyme Disease/drug therapyLyme Disease/economicsNervous System Diseases/prevention & controlQuality of LifeQuality-Adjusted Life YearsRisk
Substances: See more » Anti-Bacterial AgentsCephalosporinsCeftriaxoneDoxycycline
Year: 1997 PMID: 9233874 DOI: 10.1056/NEJM199707313370525
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245